DZ Bank AG reiterated their sell rating on shares of Carl Zeiss Meditec AG (ETR:AFX) in a report published on Tuesday morning.

AFX has been the topic of a number of other reports. Deutsche Bank AG set a €36.00 ($42.35) price objective on shares of Carl Zeiss Meditec AG and gave the company a neutral rating in a research note on Monday, June 26th. Berenberg Bank set a €48.00 ($56.47) price objective on shares of Carl Zeiss Meditec AG and gave the company a buy rating in a research note on Monday, May 29th. Nord/LB set a €52.00 ($61.18) price objective on shares of Carl Zeiss Meditec AG and gave the company a buy rating in a research note on Friday, June 2nd. Commerzbank Ag set a €42.00 ($49.41) price objective on shares of Carl Zeiss Meditec AG and gave the company a neutral rating in a research note on Wednesday, August 2nd. Finally, Independent Research GmbH set a €44.00 ($51.76) price objective on shares of Carl Zeiss Meditec AG and gave the company a neutral rating in a research note on Monday, May 29th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company. The stock currently has a consensus rating of Hold and an average target price of €45.75 ($53.82).

Shares of Carl Zeiss Meditec AG (ETR AFX) traded down 6.047% during midday trading on Tuesday, reaching €41.715. 1,878 shares of the company’s stock traded hands. The firm has a market cap of €3.73 billion and a PE ratio of 30.338. Carl Zeiss Meditec AG has a 52-week low of €30.80 and a 52-week high of €47.80. The company has a 50 day moving average of €45.44 and a 200 day moving average of €42.37.

WARNING: “Carl Zeiss Meditec AG (AFX) Stock Rating Reaffirmed by DZ Bank AG” was originally posted by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The correct version of this report can be read at https://www.dailypolitical.com/2017/08/09/carl-zeiss-meditec-ag-afx-stock-rating-reaffirmed-by-dz-bank-ag.html.

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery.

Analyst Recommendations for Carl Zeiss Meditec AG (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec AG and related companies with MarketBeat.com's FREE daily email newsletter.